CME Group stock has gained a meager 4% YTD, and at its current price of $189 per share, it is trading 13% below its fair value of $216 - Trefis' estimate for CME Group's valuation. The stock has lost approximately 11% since its second-quarter 2021 results in July, despite outperforming the...
CME Group stock has gained a meager 4% YTD, and at its current price of $189 per share, it is trading 13% below its fair value of $216 - Trefis' estimate for CME Group's valuation. The stock has lost approximately 11% since its second-quarter 2021 results in July, despite outperforming the...
Share this Article
Recommended